Zee NewsCertain Diabetes Meds May Lower Heart Failure RiskWebMDResearchers from Henry Ford Hospital in Detroit found that patients taking so-called GLP-1 drugs — including brand-name medications such as Byetta, Januvia and Victoza — were more than 40…
Insomnia can triple risk of heart failure, use these tips to prevent – eMaxHealth
 eMaxHealth |
Insomnia can triple risk of heart failure, use these tips to prevent
eMaxHealth “Insomnia is a frequent and easily recognized, potentially manageable and treatable condition,” said Laugsand, from the Norwegian University of Science and Technology. He added that his team found an association between insomnia and heart failure, but … Insomnia might boost heart failure riskVisalia Times-Delta Poor sleep linked to heart failure, Norwegian study saysPakTribune.com Chronic Insomnia Affects HeartNew York Times (blog) IrishCentral all 5 news articles » |
'This Is the End': First Look at Seth Rogen's Star-Studded Apocalypse Comedy – Moviefone
|
‘This Is the End’: First Look at Seth Rogen’s Star-Studded Apocalypse Comedy
Moviefone strong> England’s finest — Bill Nighy, Maggie Smith, Judi Dench and Tom Wilkinson — play a gaggle of retirees who want to spend their twilight years in India. The group was lured in with the promise of a cheaper and more lavish retirement at the … |
Do we have an obligation to look? – Genomes Unzipped
|
Do we have an obligation to look?
Genomes Unzipped For example, the HLA typing produced in our lab has been widely used to impute HLA types from GWAS data – but it should not be used to tissue type for transplantation, and it seems the product was withdrawn when someone tried to use it for clinical … |
Helping the brain use alternative fuel may ease symptoms of Alzheimer's – Milwaukee Journal Sentinel
|
Helping the brain use alternative fuel may ease symptoms of Alzheimer’s
Milwaukee Journal Sentinel “When blood glucose drops rapidly, significant decline in cognitive function occurs and may be accompanied by confusion, coma and even brain death.” While Axona is not a cure for Alzheimer’s, it can help some patients mitigate the symptoms of the disease. |
Computerized discharge tool cuts readmissions for heart failure patients – FierceHealthIT
Computerized discharge tool cuts readmissions for heart failure patientsFierceHealthITHospitals that used a computerized system for discharge of heart failure patients found 30-day readmission rates fell 2.5 percent compared with hospitals that did not…
'Frankenstein's Cat': Bioengineering The Animals Of The Future – WFAE
|
‘Frankenstein’s Cat’: Bioengineering The Animals Of The Future
WFAE There’s a huge shortage of organ donors worldwide, so scientists just imagine that if you could have these pig farms that are just growing organs constantly, it might save a lot of lives. The problem is … rejection. It just shows the potential of if … |
Scientists Study How Immune Cells are Able to Advance Their Own Evolution – Infection Control Today
Scientists Study How Immune Cells are Able to Advance Their Own EvolutionInfection Control TodayAntibodies and immune cells are marked with different colors. Image by University of Birmingham/Toellner. Immune system B cells play a crucial role in the d…
New Biolimus Stent Equal to Everolimus Stent at One Year – Science Daily (press release)
|
New Biolimus Stent Equal to Everolimus Stent at One Year
Science Daily (press release) The NEXT trial assigned 3,235 patients to either BES or an everolimus-eluting stent (EES) in the largest multicenter, randomized open-label study comparing these two devices ever reported. BES was approved in Japan in 2011, while EES is the country’s … NEXT: Biolimus-eluting stent comparable to everolimus-eluting stent at 1 yearHealio Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EESTCTMD |
IPO Recap: Artisan Partners Delivers Best IPO Pop From U.S. Asset Manager In … – Seeking Alpha
|
IPO Recap: Artisan Partners Delivers Best IPO Pop From U.S. Asset Manager In …
Seeking Alpha The company’s lead drug candidate is expected to begin Phase 3 trials in 2013 for the prevention of CMV (cytomegalovirus), an infection found in certain stem cell transplant patients. It also has developed a preclinical compound for the treatment of HIV. |